Registration Frequencies

Shown are frequencies of observation starts at registration by medication.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1008 274
Brodalumab 255
Certolizumab 84 0
Efalizumab 35 0
Etanercept 307 57
Golimumab 26 0
Guselkumab 525 0
Infliximab 101 1
Ixekizumab 426 0
Risankizumab 186 0
Secukinumab 1236 0
Tildrakizumab 265 0
Ustekinumab 696 0
Apremilast 497 0
Ciclosporin 386 0
Fumaderm 2596 0
Skilarence 1547 0
Methotrexate 3069 0
other systemics 324 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers